Literature DB >> 30624253

One Actor, Many Roles: Histopathologies Associated With APOL1 Genetic Variants.

Jeffrey B Kopp1,2, Avi Z Rosenberg1,2.   

Abstract

Genetic variants in APOL1, encoding apolipoprotein L1, are major drivers of glomerular disease in peoples of sub-Saharan African descent. APOL1-associated primary glomerular diseases include focal segmental glomerulosclerosis, human immunodeficiency virus-associated nephropathies, and arterionephrosclerosis. Other conditions where APOL1 variants affect outcomes include membranous nephropathy, lupus nephritis, diabetic nephropathy, preeclampsia, and kidney transplant. In focal segmental glomerulosclerosis, APOL1 variants are associated with upregulation of RNA encoding chemokine C-X-C motif receptor 3 ligands and ubiquitin D; the significance of these findings remains unclear but may provide valuable insight into disease mechanisms.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30624253      PMCID: PMC6458071          DOI: 10.1097/PAP.0000000000000221

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  32 in total

Review 1.  Subtle acquired renal injury as a mechanism of salt-sensitive hypertension.

Authors:  Richard J Johnson; Jaime Herrera-Acosta; George F Schreiner; Bernardo Rodriguez-Iturbe
Journal:  N Engl J Med       Date:  2002-03-21       Impact factor: 91.245

2.  Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

Authors:  Giulio Genovese; David J Friedman; Michael D Ross; Laurence Lecordier; Pierrick Uzureau; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Taras K Oleksyk; Andrea L Uscinski Knob; Andrea J Bernhardy; Pamela J Hicks; George W Nelson; Benoit Vanhollebeke; Cheryl A Winkler; Jeffrey B Kopp; Etienne Pays; Martin R Pollak
Journal:  Science       Date:  2010-07-15       Impact factor: 47.728

3.  Blockade of IP-10/CXCR3 promotes progressive renal fibrosis.

Authors:  Izaya Nakaya; Takashi Wada; Kengo Furuichi; Norihiko Sakai; Kiyoki Kitagawa; Hitoshi Yokoyama; Yuko Ishida; Toshikazu Kondo; Takeshi Sugaya; Hiroshi Kawachi; Fujio Shimizu; Shosaku Narumi; Makoto Haino; Craig Gerard; Kouji Matsushima; Shuichi Kaneko
Journal:  Nephron Exp Nephrol       Date:  2007-07-18

4.  MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.

Authors:  Jeffrey B Kopp; Michael W Smith; George W Nelson; Randall C Johnson; Barry I Freedman; Donald W Bowden; Taras Oleksyk; Louise M McKenzie; Hiroshi Kajiyama; Tejinder S Ahuja; Jeffrey S Berns; William Briggs; Monique E Cho; Richard A Dart; Paul L Kimmel; Stephen M Korbet; Donna M Michel; Michele H Mokrzycki; Jeffrey R Schelling; Eric Simon; Howard Trachtman; David Vlahov; Cheryl A Winkler
Journal:  Nat Genet       Date:  2008-09-14       Impact factor: 38.330

5.  IFN-inducible protein-10 plays a pivotal role in maintaining slit-diaphragm function by regulating podocyte cell-cycle balance.

Authors:  Gi Dong Han; Koichi Suzuki; Hiroko Koike; Kenji Suzuki; Hiroyuki Yoneyama; Shosaku Narumi; Fujio Shimizu; Hiroshi Kawachi
Journal:  J Am Soc Nephrol       Date:  2005-12-28       Impact factor: 10.121

6.  APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.

Authors:  Jeffrey B Kopp; George W Nelson; Karmini Sampath; Randall C Johnson; Giulio Genovese; Ping An; David Friedman; William Briggs; Richard Dart; Stephen Korbet; Michele H Mokrzycki; Paul L Kimmel; Sophie Limou; Tejinder S Ahuja; Jeffrey S Berns; Justyna Fryc; Eric E Simon; Michael C Smith; Howard Trachtman; Donna M Michel; Jeffrey R Schelling; David Vlahov; Martin Pollak; Cheryl A Winkler
Journal:  J Am Soc Nephrol       Date:  2011-10-13       Impact factor: 10.121

7.  MYH9 is associated with nondiabetic end-stage renal disease in African Americans.

Authors:  W H Linda Kao; Michael J Klag; Lucy A Meoni; David Reich; Yvette Berthier-Schaad; Man Li; Josef Coresh; Nick Patterson; Arti Tandon; Neil R Powe; Nancy E Fink; John H Sadler; Matthew R Weir; Hanna E Abboud; Sharon G Adler; Jasmin Divers; Sudha K Iyengar; Barry I Freedman; Paul L Kimmel; William C Knowler; Orly F Kohn; Kristopher Kramp; David J Leehey; Susanne B Nicholas; Madeleine V Pahl; Jeffrey R Schelling; John R Sedor; Denyse Thornley-Brown; Cheryl A Winkler; Michael W Smith; Rulan S Parekh
Journal:  Nat Genet       Date:  2008-09-14       Impact factor: 38.330

8.  Expression of functional CCR and CXCR chemokine receptors in podocytes.

Authors:  Tobias Bruno Huber; Hans Christian Reinhardt; Markus Exner; Jan Andreas Burger; Dontscho Kerjaschki; Moin A Saleem; Hermann Pavenstädt
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

9.  Increased urinary levels of CXCL5, CXCL8 and CXCL9 in patients with Type 2 diabetic nephropathy.

Authors:  Mayumi Higurashi; Yoshiyuki Ohya; Kensuke Joh; Masahiro Muraguchi; Motonobu Nishimura; Hiroyuki Terawaki; Kazuo Yagui; Naotake Hashimoto; Yasushi Saito; Kenichi Yamada
Journal:  J Diabetes Complications       Date:  2008-04-16       Impact factor: 2.852

10.  Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.

Authors:  Shay Tzur; Saharon Rosset; Revital Shemer; Guennady Yudkovsky; Sara Selig; Ayele Tarekegn; Endashaw Bekele; Neil Bradman; Walter G Wasser; Doron M Behar; Karl Skorecki
Journal:  Hum Genet       Date:  2010-07-16       Impact factor: 4.132

View more
  2 in total

1.  APOL1 Genetic Variants Are Associated With Increased Risk of Coronary Atherosclerotic Plaque Rupture in the Black Population.

Authors:  Anne Cornelissen; Daniela T Fuller; Raquel Fernandez; Xiaoqing Zhao; Robert Kutys; Elizabeth Binns-Roemer; Marco Delsante; Atsushi Sakamoto; Ka Hyun Paek; Yu Sato; Rika Kawakami; Masayuki Mori; Kenji Kawai; Teruhiko Yoshida; Khun Zaw Latt; Clint L Miller; Paul S de Vries; Frank D Kolodgie; Renu Virmani; Myung Kyun Shin; Maarten Hoek; Jurgen Heymann; Jeffrey B Kopp; Avi Z Rosenberg; Harry R Davis; Liang Guo; Aloke V Finn
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-05-27       Impact factor: 10.514

Review 2.  The Role of Chemokines and Chemokine Receptors in Diabetic Nephropathy.

Authors:  Ting-Ting Chang; Jaw-Wen Chen
Journal:  Int J Mol Sci       Date:  2020-04-30       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.